This 4-hour course is designed for medical providers practicing addiction medicine who interact with treatment courts and the justice system. Clinicians will explore the complexities of treating justice-involved individuals and apply practical strategies through case-based learning to enhance collaboration, advocate for evidence-based care, and improve coordination with community resources.

This 6-hour, live-virtual course is the recommended first step to understanding the ASAM Criteria 4th Edition and covers developing patient-centered service plans as well as making objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions.

This two-day course includes the ASAM Criteria 4th Edition Foundations Course and the ASAM Criteria 4th Skill-Building Course at a discounted rate. Each course provides the tools to utilize the ASAM Criteria with the utmost care and evidence-based practice.

This 8-hour live virtual course expands on the content discussed within the ASAM Criteria 3rd Edition One-Day Foundations course and provides an in-depth understanding of developing individualized treatment plans, evaluating initial reviews and continued stay reviews, and determining when it is appropriate to initiate transfer or discharge of a patient from treatment.

This 4-hour course is designed for medical providers practicing addiction medicine who interact with treatment courts and the justice system. Clinicians will explore the complexities of treating justice-involved individuals and apply practical strategies through case-based learning to enhance collaboration, advocate for evidence-based care, and improve coordination with community resources.

This 8-hour, online course will provide an overview of the basics of addiction medicine needed to screen, diagnose, treat and/or refer patients with addiction

In this episode of ASAM Practice Pearls, Dr. Stephen Taylor welcomes back Dr. Stephanie Weiss and is joined by Dr. Anna Lembke to explore an update on GLP-1 receptor agonists for alcohol use disorder (AUD), discussing current research, how things have evolved since the last discussion, and the challenges and implications of integrating these innovative treatments into addiction care.

In this episode of ASAM Practice Pearls, Dr. Stephen Taylor hosts Dr. Justin Berk to discuss addiction care for individuals involved in the criminal justice system, including patients in custody and those transitioning back to the community. The conversation explores practical strategies for building therapeutic alliances with incarcerated patients, advocating for evidence-based treatment in correctional settings, and navigating common barriers to care. The episode covers opportunities for clinicians to provide compassionate, patient-centered care that improves outcomes for this high-risk population.

This one-hour, journal article-based activity examines associations between social-environmental vulnerability (SEV), healthcare service presence, and opioid overdose rate acceleration across rural and urban communities in the United States. Learners will explore how vulnerability and geographic context are associated with differences in overdose trends and examine the relationship between the presence of opioid treatment programs (OTPs) and primary care providers (PCPs) services and overdose rate acceleration. The article also considers how healthcare service presence in high-vulnerability communities may inform strategies to address geographic and social disparities in opioid overdose outcomes.

This one-hour, journal article-based activity examines the efficacy and safety of methylphenidate (MPH) for the treatment of cocaine use disorder (CUD). Learners will explore findings from a systematic review and meta-analysis evaluating the effects of MPH on cocaine craving and use, including differences in outcomes among individuals with and without co-occurring attention-deficit/hyperactivity disorder (ADHD). The article also examines factors that may influence treatment outcomes, considerations related to the safety of MPH, and limitations in the current evidence base to inform future research and clinical practice.